asx:rac

1:28:47

Race Oncology (ASX:RAC) 2024 Annual General Meeting

0:33:20

Race Oncology (ASX:RAC) | Webinar with Daniel Tillett | 05/06/24

0:06:05

Race Oncology on RC220 ethics, 2024 milestones and 2025 outlook

0:20:31

Race Oncology (ASX: RAC) – Zantrene’s Role As An FTO Inhibitor To Cure Cancer Globally

0:06:42

Race Oncology (ASX: RAC) reveals breakthrough chemotherapy heart protection discovery for Zantrene®

0:05:20

Race Oncology (ASX:RAC) leukemia drug candidate update

0:12:59

Race Oncology (ASX:RAC) CEO, Phillip Lynch presents at V-Con

0:54:22

Race Oncology (ASX:RAC) Investor Briefing - Melbourne 20th Oct 2022

0:54:51

Race Oncology (ASX: RAC) Investor briefing - May 2021

0:19:11

ShareCafe 'Hidden Gems' Webinar - Race Oncology ASX:RAC

0:08:11

Race CEO Daniel Tillett Joins Hot Copper webinar to discuss bringing medical developments to market

0:02:08

Top ASX Biotech Stocks for 2024

0:32:00

Race Oncology (ASX: RAC) Day 2 of the IRD Invest 2021 conference.

0:32:00

Race Oncology (ASX: RAC) Day 2 of the IRD Invest 2021 conference.

0:08:20

Race Oncology at the heart of cancer care

0:04:52

Race Oncology advances RNA epigenetics with FTO drug discovery at Monash

0:05:17

Race Oncology AGM 2021 Share Purchase Plan Explained

0:03:25

Race Oncology poised for observational heart protection breast cancer trial

0:07:23

Q&A With StockPal - Race Oncology (ASX:RAC)

0:04:16

Race Oncology's breakthrough in cancer cell treatment

0:07:51

Race Oncology (RAC) - ASX Stock Analysis 21st January 2022

0:27:43

Race presents at IRD Invest

0:02:45

Race Oncology welcomes positive pre-IND meeting for Zantrene

0:09:40

Q&A With StockPal - Race Oncology (ASX:RAC)